Europe · Markets & Finance · BFM Bourse

Medincell: Les États-Unis autorisent la mise sur le marché de Weltruza, son traitement de la schizophrénie, Medincell s'envole de 18% en Bourse

Published by BFM Bourse · France 1 d ago

(BFM Bourse) - La biopharma française franchit une étape majeure avec l’approbation américaine de Weltruza, une formulation injectable sous-cutanée ...

Read the full article on BFM Bourse Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tradingsat.com)

Also worth reading

Financial Times

US warns Kyiv that strikes on Russia jeopardise intelligence-sharing

This is Money

My neighbour put up a sign for her hairdressing business on my drive without asking: What should I do?

City A.M.

Medincell: Les États-Unis autorisent la mise sur le marché de Weltruza, son traitement de la schizophrénie, Medincell s'envole de 18% en Bourse

Share

Also worth reading

US warns Kyiv that strikes on Russia jeopardise intelligence-sharing

My neighbour put up a sign for her hairdressing business on my drive without asking: What should I do?

Where to eat Greek food in central London

India detains youth protest leader to defuse rally against election chief

8 of the best houses for sale in elevated locations

Aussie extends weekly gains as Fed pause bets offset hawkish rhetoric